首页 > 最新文献

Mayo Clinic proceedings. Innovations, quality & outcomes最新文献

英文 中文
Females Display Lower Risk of Myocardial Infarction From Higher Estimated Cardiorespiratory Fitness Than Males: The Tromsø Study 1994-2014 女性的心肺功能估计值高于男性,因而心肌梗死风险较低:1994-2014 年特罗姆瑟研究
Pub Date : 2024-01-06 DOI: 10.1016/j.mayocpiqo.2023.12.007
Edvard H. Sagelv PhD , Andrea Casolo PhD , Anne Elise Eggen PhD , Kim Arne Heitmann PhD , Kristoffer R. Johansen MSc , Maja-Lisa Løchen PhD , Ellisiv B. Mathiesen PhD , Bente Morseth PhD , Inger Njølstad PhD , John O. Osborne PhD , Karianne Hagerupsen MSc , Sigurd Pedersen PhD , Tom Wilsgaard PhD

Objective

To examine the dose-response association between estimated cardiorespiratory fitness (eCRF) and risk of myocardial infarction (MI).

Patients and Methods

Adults who attended Tromsø Study surveys 4-6 (Janurary 1,1994-December 20, 2008) with no previous cardiovascular disease were followed up through December 31, 2014 for incident MI. Associations were examined using restricted cubic splines Fine and Gray regressions, adjusted for education, smoking, alcohol, diet, sex, adiposity, physical activity, study survey, and age (timescale) in the total cohort and subsamples with hyperlipidemia (n=2956), hypertension (n=8290), obesity (n=5784), metabolic syndrome (n=1410), smokers (n=3823), and poor diet (n=3463) and in those who were physically inactive (n=6255).

Results

Of 14,285 participants (mean age ± SD, 53.7±11.4 years), 979 (6.9%) experienced MI during follow-up (median, 7.2 years; 25th-75th, 5.3-14.6 years). Females with median eCRF (32 mL/kg/min) had 43% lower MI risk (subdistributed hazard ratio [SHR], 0.57; 95% CI, 0.48-0.68) than those at the 10th percentile (25 mL/kg/min) as reference. The lowest MI risk was observed at 47 mL/kg/min (SHR, 0.02; 95% CI, 0.01-0.11). Males had 26% lower MI risk at median eCRF (40 mL/kg/min; SHR, 0.74; 95% CI, 0.63-0.86) than those at the 10th percentile (32 mL/kg/min), and the lowest risk was 69% (SHR, 0.31; 95% CI, 0.14-0.71) at 60 mL/kg/min. The associations were similar in subsamples with cardiovascular disease risk factors.

Conclusion

Higher eCRF associated with lower MI risk in females and males, but associations were more pronounced among females than those in males. This suggest eCRF as a vital estimate to implement in medical care to identify individuals at high risk of future MI, especially for females.

患者和方法对参加特罗姆瑟研究调查 4-6 期(1994 年 1 月 1 日至 2008 年 12 月 20 日)、既往未患心血管疾病的成人进行随访,直至 2014 年 12 月 31 日,以了解其是否发生心肌梗死。使用限制性三次样条Fine和Gray回归对相关性进行了研究,并对教育、吸烟、饮酒、饮食、性别、肥胖、体力活动、研究调查进行了调整、和年龄(时间尺度)的相关性进行了研究,研究对象包括总体样本、高脂血症(n=2956)、高血压(n=8290)、肥胖(n=5784)、代谢综合征(n=1410)、吸烟者(n=3823)、不良饮食(n=3463)和缺乏运动者(n=6255)。结果 在14285名参与者(平均年龄±SD,53.7±11.4岁)中,有979人(6.9%)在随访期间(中位数,7.2年;第25-75位,5.3-14.6年)发生过心肌梗死。eCRF 中位数(32 mL/kg/min)女性的心肌梗死风险比参考值第 10 百分位数(25 mL/kg/min)女性低 43%(亚分布危险比 [SHR],0.57;95% CI,0.48-0.68)。47 毫升/千克/分钟时,心肌梗死风险最低(SHR,0.02;95% CI,0.01-0.11)。男性的心肌梗死风险在 eCRF 中位数(40 毫升/千克/分钟;SHR,0.74;95% CI,0.63-0.86)时比在第 10 百分位数(32 毫升/千克/分钟)时低 26%,在 60 毫升/千克/分钟时最低风险为 69%(SHR,0.31;95% CI,0.14-0.71)。结论女性和男性的 eCRF 越高,心肌梗死风险越低,但女性的相关性比男性更明显。这表明,eCRF 是医疗护理中识别未来心肌梗死高风险人群(尤其是女性)的重要估算指标。
{"title":"Females Display Lower Risk of Myocardial Infarction From Higher Estimated Cardiorespiratory Fitness Than Males: The Tromsø Study 1994-2014","authors":"Edvard H. Sagelv PhD ,&nbsp;Andrea Casolo PhD ,&nbsp;Anne Elise Eggen PhD ,&nbsp;Kim Arne Heitmann PhD ,&nbsp;Kristoffer R. Johansen MSc ,&nbsp;Maja-Lisa Løchen PhD ,&nbsp;Ellisiv B. Mathiesen PhD ,&nbsp;Bente Morseth PhD ,&nbsp;Inger Njølstad PhD ,&nbsp;John O. Osborne PhD ,&nbsp;Karianne Hagerupsen MSc ,&nbsp;Sigurd Pedersen PhD ,&nbsp;Tom Wilsgaard PhD","doi":"10.1016/j.mayocpiqo.2023.12.007","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.12.007","url":null,"abstract":"<div><h3>Objective</h3><p>To examine the dose-response association between estimated cardiorespiratory fitness (eCRF) and risk of myocardial infarction (MI).</p></div><div><h3>Patients and Methods</h3><p>Adults who attended Tromsø Study surveys 4-6 (Janurary 1,1994-December 20, 2008) with no previous cardiovascular disease were followed up through December 31, 2014 for incident MI. Associations were examined using restricted cubic splines Fine and Gray regressions, adjusted for education, smoking, alcohol, diet, sex, adiposity, physical activity, study survey, and age (timescale) in the total cohort and subsamples with hyperlipidemia (n=2956), hypertension (n=8290), obesity (n=5784), metabolic syndrome (n=1410), smokers (n=3823), and poor diet (n=3463) and in those who were physically inactive (n=6255).</p></div><div><h3>Results</h3><p>Of 14,285 participants (mean age ± SD, 53.7±11.4 years), 979 (6.9%) experienced MI during follow-up (median, 7.2 years; 25th-75th, 5.3-14.6 years). Females with median eCRF (32 mL/kg/min) had 43% lower MI risk (subdistributed hazard ratio [SHR], 0.57; 95% CI, 0.48-0.68) than those at the 10th percentile (25 mL/kg/min) as reference. The lowest MI risk was observed at 47 mL/kg/min (SHR, 0.02; 95% CI, 0.01-0.11). Males had 26% lower MI risk at median eCRF (40 mL/kg/min; SHR, 0.74; 95% CI, 0.63-0.86) than those at the 10th percentile (32 mL/kg/min), and the lowest risk was 69% (SHR, 0.31; 95% CI, 0.14-0.71) at 60 mL/kg/min. The associations were similar in subsamples with cardiovascular disease risk factors.</p></div><div><h3>Conclusion</h3><p>Higher eCRF associated with lower MI risk in females and males, but associations were more pronounced among females than those in males. This suggest eCRF as a vital estimate to implement in medical care to identify individuals at high risk of future MI, especially for females.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 62-73"},"PeriodicalIF":0.0,"publicationDate":"2024-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000826/pdfft?md5=faf6ca2d58c1b47ae0380a6e7c317a24&pid=1-s2.0-S2542454823000826-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139111519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Expanding Scope of Alpha 1 Antitrypsin Deficiency 阿尔法 1 型抗胰蛋白酶缺乏症的范围不断扩大
Pub Date : 2024-01-06 DOI: 10.1016/j.mayocpiqo.2023.12.001
Friedrich Kueppers MD
{"title":"The Expanding Scope of Alpha 1 Antitrypsin Deficiency","authors":"Friedrich Kueppers MD","doi":"10.1016/j.mayocpiqo.2023.12.001","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.12.001","url":null,"abstract":"","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 58-61"},"PeriodicalIF":0.0,"publicationDate":"2024-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000760/pdfft?md5=a1663219cf14da6138b5036a565c14de&pid=1-s2.0-S2542454823000760-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139107408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Daylight Saving Time Practice and the Rate of Adverse Cardiovascular Events in the United States: A Probabilistic Assessment in a Large Nationwide Study 美国的夏令时做法与不良心血管事件发生率:一项大型全国性研究的概率评估
Pub Date : 2024-01-05 DOI: 10.1016/j.mayocpiqo.2023.12.006
Benjamin A. Satterfield MD, PhD , Ozan Dikilitas MD , Holly Van Houten BA , Xiaoxi Yao PhD, MPH , Bernard J. Gersh MBChB, DPhil

We investigated the association of daylight saving time (DST) transitions with the rates of adverse cardiovascular events in a large, US-based nationwide study. The study cohort included 36,116,951 unique individuals from deidentified administrative claims data of the OptumLabs Data Warehouse. There were 74,722 total adverse cardiovascular events during DST transition and the control weeks (2 weeks before and after) in spring and autumn of 2015-2019. We used Bayesian hierarchical Poisson regression models to estimate event rate ratios representing the ratio of composite adverse cardiovascular event rates between DST transition and control weeks. There was an average increase of 3% (95% uncertainty interval, −3% to −10%) and 4% (95% uncertainty interval, −2% to −12%) in adverse cardiovascular event rates during Monday and Friday of the spring DST transition, respectively. The probability of this being associated with a moderate-to-large increase in the event rates (estimate event rate ratio, >1.10) was estimated to be less than 6% for Monday and Friday, and less than 1% for the remaining days. During autumn DST transition, the probability of any decrease in adverse cardiovascular event rates was estimated to be less than 46% and a moderate-to-large decrease in the event rates to be less than 4% across all days. Results were similar when adjusted by age. In conclusion, spring DST transition had a suggestive association with a minor increase in adverse cardiovascular event rates but with a very low estimated probability to be of clinical importance. Our findings suggest that DST transitions are unlikely to meaningfully impact the rate of cardiovascular events.

我们在一项大型的美国全国性研究中调查了夏令时(DST)转换与不良心血管事件发生率之间的关系。研究队列包括 OptumLabs 数据仓库中 36,116,951 名来自去标识化行政索赔数据的独特个体。在 2015 年春季和 2019 年秋季的 DST 过渡期和对照周(前后 2 周)期间,共发生了 74,722 起不良心血管事件。我们使用贝叶斯分层泊松回归模型估算了事件发生率比,该比率代表了 DST 过渡周和对照周之间的心血管不良事件综合发生率比。在春季夏令时过渡期的周一和周五,不良心血管事件发生率分别平均增加了 3%(95% 不确定区间,-3% 至 -10%)和 4%(95% 不确定区间,-2% 至 -12%)。据估计,这与事件发生率的中度至大幅上升(估计事件发生率比值,>1.10)有关的概率在周一和周五小于 6%,在其余日期小于 1%。在秋季夏令时过渡期间,心血管不良事件发生率下降的概率估计小于 46%,所有日期的事件发生率中度至大幅下降的概率估计小于 4%。根据年龄进行调整后,结果类似。总之,春季夏令时转换与心血管不良事件发生率的轻微增加有提示性关联,但具有临床重要性的估计概率非常低。我们的研究结果表明,夏令时转换不太可能对心血管事件的发生率产生有意义的影响。
{"title":"Daylight Saving Time Practice and the Rate of Adverse Cardiovascular Events in the United States: A Probabilistic Assessment in a Large Nationwide Study","authors":"Benjamin A. Satterfield MD, PhD ,&nbsp;Ozan Dikilitas MD ,&nbsp;Holly Van Houten BA ,&nbsp;Xiaoxi Yao PhD, MPH ,&nbsp;Bernard J. Gersh MBChB, DPhil","doi":"10.1016/j.mayocpiqo.2023.12.006","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.12.006","url":null,"abstract":"<div><p>We investigated the association of daylight saving time (DST) transitions with the rates of adverse cardiovascular events in a large, US-based nationwide study. The study cohort included 36,116,951 unique individuals from deidentified administrative claims data of the OptumLabs Data Warehouse. There were 74,722 total adverse cardiovascular events during DST transition and the control weeks (2 weeks before and after) in spring and autumn of 2015-2019. We used Bayesian hierarchical Poisson regression models to estimate event rate ratios representing the ratio of composite adverse cardiovascular event rates between DST transition and control weeks. There was an average increase of 3% (95% uncertainty interval, −3% to −10%) and 4% (95% uncertainty interval, −2% to −12%) in adverse cardiovascular event rates during Monday and Friday of the spring DST transition, respectively. The probability of this being associated with a moderate-to-large increase in the event rates (estimate event rate ratio, &gt;1.10) was estimated to be less than 6% for Monday and Friday, and less than 1% for the remaining days. During autumn DST transition, the probability of any decrease in adverse cardiovascular event rates was estimated to be less than 46% and a moderate-to-large decrease in the event rates to be less than 4% across all days. Results were similar when adjusted by age. In conclusion, spring DST transition had a suggestive association with a minor increase in adverse cardiovascular event rates but with a very low estimated probability to be of clinical importance. Our findings suggest that DST transitions are unlikely to meaningfully impact the rate of cardiovascular events.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 45-52"},"PeriodicalIF":0.0,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000814/pdfft?md5=8383a94342c93556eb14bd0bb98b66ae&pid=1-s2.0-S2542454823000814-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139107410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical Restraint Usage in Hospitals Across the United States: 2011-2019 全美医院使用物理约束的情况:2011-2019
Pub Date : 2024-01-04 DOI: 10.1016/j.mayocpiqo.2023.12.003
Ishaan Gupta MBBS, Ilana Nelson-Greenberg MD, Scott Mitchell Wright MD, Ché Matthew Harris MD, MS

Objective

To determine the change in rates of physical restraint (PR) use and associated outcomes among hospitalized adults.

Patients and Methods

Using national inpatient sample databases, we analyzed years 2011-2014 and 2016-2019 to determine trends of PR usage. We also compared the years 2011-2012 and 2018-2019 to investigate rates of PR use, in-hospital mortality, length of stay, and total hospital charges.

Results

There were 242,994,110 hospitalizations during the study period. 1,538,791 (0.63%) had coding to signify PRs, compared with 241,455,319 (99.3%), which did not. From 2011 to 2014, there was a significant increase in PR use (p-trend<.01) and a nonsignificant increase in PR rates from 2016-2019 (p-trend=.07). Over time, PR use increased (2011-2012: 0.52% vs 2018-2019: 0.73%; p<.01). Patients with PRs reported a higher adjusted odds for in-hospital mortality in 2011-2012 (adjusted odds ratio [aOR], 3.9; 95% CI, 3.7-4.2; p<.01) and 2018-2019 (aOR, 3.5; 95% CI, 3.4-3.7; p<.01). Length of stay was prolonged for patients with PRs in 2011-2012 (adjusted mean difference [aMD], 4.3 days; 95% CI, 4.1-4.5; p<.01) and even longer in 2018-2019 (aMD, 5.8 days; 95% CI, 5.6-6.0; p<.01). Total hospital charges were higher for patients with PRs in 2011-2012 (aMD, +$55,003; 95% CI, $49,309-$60,679; p<.01). Following adjustment for inflation, total charges remained higher for patients with PRs compared with those without PRs in 2018-2019 (aMD, +$70,018; 95% CI, $65,355-$74,680; p<.01).

Conclusion

Overall, PR rates did not decrease across the study period, suggesting that messaging and promulgating best practice guidelines have yet to translate into a substantive change in practice patterns.

目标确定住院成人中物理约束(PR)使用率的变化及相关结果。患者和方法我们利用全国住院病人样本数据库,分析了 2011-2014 年和 2016-2019 年的数据,以确定 PR 的使用趋势。我们还对 2011-2012 年和 2018-2019 年进行了比较,以调查 PR 的使用率、院内死亡率、住院时间和医院总费用。1,538,791次(0.63%)有编码标识为PR,而241,455,319次(99.3%)没有。从 2011 年到 2014 年,PR 的使用显著增加(p-trend<.01),而从 2016 年到 2019 年,PR 率的增加并不显著(p-trend=.07)。随着时间的推移,PR 使用率有所增加(2011-2012 年:0.52% vs 2018-2019 年:0.73%;p<.01)。2011-2012年(调整赔率比 [aOR],3.9;95% CI,3.7-4.2;p<.01)和2018-2019年(aOR,3.5;95% CI,3.4-3.7;p<.01)使用PR的患者院内死亡率调整赔率较高。2011-2012年,PR患者的住院时间延长(调整后平均差异[aMD],4.3天;95% CI,4.1-4.5;p<.01),2018-2019年的住院时间更长(aMD,5.8天;95% CI,5.6-6.0;p<.01)。2011-2012 年 PR 患者的住院总费用更高(aMD,+55,003 美元;95% CI,49,309-60,679 美元;p<.01)。经通货膨胀调整后,2018-2019 年有 PR 患者的总费用仍高于无 PR 患者(aMD,+$70,018;95% CI,$65,355-$74,680;p<.01).结论总体而言,PR 率在整个研究期间并未下降,这表明最佳实践指南的宣传和颁布尚未转化为实践模式的实质性改变。
{"title":"Physical Restraint Usage in Hospitals Across the United States: 2011-2019","authors":"Ishaan Gupta MBBS,&nbsp;Ilana Nelson-Greenberg MD,&nbsp;Scott Mitchell Wright MD,&nbsp;Ché Matthew Harris MD, MS","doi":"10.1016/j.mayocpiqo.2023.12.003","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.12.003","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the change in rates of physical restraint (PR) use and associated outcomes among hospitalized adults.</p></div><div><h3>Patients and Methods</h3><p>Using national inpatient sample databases, we analyzed years 2011-2014 and 2016-2019 to determine trends of PR usage. We also compared the years 2011-2012 and 2018-2019 to investigate rates of PR use, in-hospital mortality, length of stay, and total hospital charges.</p></div><div><h3>Results</h3><p>There were 242,994,110 hospitalizations during the study period. 1,538,791 (0.63%) had coding to signify PRs, compared with 241,455,319 (99.3%), which did not. From 2011 to 2014, there was a significant increase in PR use (<em>p-</em>trend&lt;.01) and a nonsignificant increase in PR rates from 2016-2019 (<em>p-</em>trend=.07). Over time, PR use increased (2011-2012: 0.52% vs 2018-2019: 0.73%; <em>p</em>&lt;.01). Patients with PRs reported a higher adjusted odds for in-hospital mortality in 2011-2012 (adjusted odds ratio [aOR], 3.9; 95% CI, 3.7-4.2; <em>p</em>&lt;.01) and 2018-2019 (aOR, 3.5; 95% CI, 3.4-3.7; <em>p</em>&lt;.01). Length of stay was prolonged for patients with PRs in 2011-2012 (adjusted mean difference [aMD], 4.3 days; 95% CI, 4.1-4.5; <em>p</em>&lt;.01) and even longer in 2018-2019 (aMD, 5.8 days; 95% CI, 5.6-6.0; <em>p</em>&lt;.01). Total hospital charges were higher for patients with PRs in 2011-2012 (aMD, +$55,003; 95% CI, $49,309-$60,679; <em>p</em>&lt;.01). Following adjustment for inflation, total charges remained higher for patients with PRs compared with those without PRs in 2018-2019 (aMD, +$70,018; 95% CI, $65,355-$74,680; <em>p</em>&lt;.01).</p></div><div><h3>Conclusion</h3><p>Overall, PR rates did not decrease across the study period, suggesting that messaging and promulgating best practice guidelines have yet to translate into a substantive change in practice patterns.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 37-44"},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000784/pdfft?md5=251e31df642d392cd42bba037377ce0e&pid=1-s2.0-S2542454823000784-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139107407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Surgical and Percutaneous Cardiac Interventions for Adults With Down Syndrome 手术和经皮心脏介入治疗唐氏综合征成人的安全性和有效性
Pub Date : 2023-12-26 DOI: 10.1016/j.mayocpiqo.2023.11.002
Kaitlin Roehl PA-C , Carolyn Mead-Harvey MS , Heidi M. Connolly MD , Joseph A. Dearani MD , Felicia S. Schaap APRN, AGACNP-BC , Susanna L. Liljenstolpe APRN, FNP-C , Linda B. Osborn RN , C. Charles Jain MD , Donald J. Hagler Sr. MD , Francois Marcotte MD , David S. Majdalany MD

Objective

To assess risks and benefits of cardiac intervention in adults with Down syndrome (DS).

Patients and Methods

A retrospective review was conducted using data from a study we published in 2010. Patients aged 18 years or older with DS who underwent cardiac operation or percutaneous intervention from February 2009 through April 2022 (new cohort) were compared with patients in the previous study (January 1969 through November 2007; remote cohort) at Mayo Clinic.

Results

In total, 81 adults (43 men; 38 women) with DS underwent 89 cardiac interventions (84 surgical; 5 percutaneous) at a mean age of 33 years. Twenty-six patients presented with complete atrioventricular canal defect (17%) or tetralogy of Fallot (15%). The most common adult procedures were valve interventions: mitral (31%), tricuspid (15%), and pulmonary (12%). Of pulmonary valve interventions in the new cohort, 33% were performed percutaneously. The postoperative mortality rate was low (1% total). The mean time between last operation and death was 16 years.

Conclusion

Adults with DS can undergo cardiac operation and percutaneous intervention with low morbidity and mortality risk and good long-term survival.

目的评估唐氏综合征(DS)成人患者接受心脏介入治疗的风险和益处。患者和方法利用我们于 2010 年发表的一项研究的数据进行了回顾性研究。将 2009 年 2 月至 2022 年 4 月期间接受心脏手术或经皮介入治疗的 18 岁或以上 DS 患者(新队列)与梅奥诊所之前研究(1969 年 1 月至 2007 年 11 月;远程队列)中的患者进行比较。结果共有 81 名成人 DS 患者(43 名男性;38 名女性)接受了 89 次心脏介入治疗(84 次手术;5 次经皮),平均年龄为 33 岁。26名患者伴有完全性房室管缺损(17%)或法洛氏四联症(15%)。最常见的成人手术是瓣膜介入:二尖瓣(31%)、三尖瓣(15%)和肺动脉瓣(12%)。在新组群中,33%的肺动脉瓣介入手术是经皮进行的。术后死亡率很低(1%)。结论:DS成人可以接受心脏手术和经皮介入治疗,发病率和死亡率较低,长期存活率较高。
{"title":"Safety and Efficacy of Surgical and Percutaneous Cardiac Interventions for Adults With Down Syndrome","authors":"Kaitlin Roehl PA-C ,&nbsp;Carolyn Mead-Harvey MS ,&nbsp;Heidi M. Connolly MD ,&nbsp;Joseph A. Dearani MD ,&nbsp;Felicia S. Schaap APRN, AGACNP-BC ,&nbsp;Susanna L. Liljenstolpe APRN, FNP-C ,&nbsp;Linda B. Osborn RN ,&nbsp;C. Charles Jain MD ,&nbsp;Donald J. Hagler Sr. MD ,&nbsp;Francois Marcotte MD ,&nbsp;David S. Majdalany MD","doi":"10.1016/j.mayocpiqo.2023.11.002","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.11.002","url":null,"abstract":"<div><h3>Objective</h3><p>To assess risks and benefits of cardiac intervention in adults with Down syndrome (DS).</p></div><div><h3>Patients and Methods</h3><p>A retrospective review was conducted using data from a study we published in 2010. Patients aged 18 years or older with DS who underwent cardiac operation or percutaneous intervention from February 2009 through April 2022 (new cohort) were compared with patients in the previous study (January 1969 through November 2007; remote cohort) at Mayo Clinic.</p></div><div><h3>Results</h3><p>In total, 81 adults (43 men; 38 women) with DS underwent 89 cardiac interventions (84 surgical; 5 percutaneous) at a mean age of 33 years. Twenty-six patients presented with complete atrioventricular canal defect (17%) or tetralogy of Fallot (15%). The most common adult procedures were valve interventions: mitral (31%), tricuspid (15%), and pulmonary (12%). Of pulmonary valve interventions in the new cohort, 33% were performed percutaneously. The postoperative mortality rate was low (1% total). The mean time between last operation and death was 16 years.</p></div><div><h3>Conclusion</h3><p>Adults with DS can undergo cardiac operation and percutaneous intervention with low morbidity and mortality risk and good long-term survival.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 28-36"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000735/pdfft?md5=adb10ed4913539d603291b2c058c3d1c&pid=1-s2.0-S2542454823000735-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139050152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electronic Consultations in a Community Neurology Practice: A Retrospective Study Informing Best Practice 社区神经病学实践中的电子会诊:为最佳实践提供依据的回顾性研究
Pub Date : 2023-12-25 DOI: 10.1016/j.mayocpiqo.2023.11.003
Nathan A. Seven MD , Karen A. Truitt DO , Ross A. Dierkhising MS , Nathan P. Young DO

Objective

To describe our practice of electronic consultations (e-consults) and assess safety and risk factors for subsequent face-to-face consultations.

Patients and Methods

A retrospective cohort study of all e-consults completed in a community neurology practice between May 5, 2018, and June 31, 2019, was completed. Clinical and demographic variables were compared between the successful and unsuccessful (defined by presence of subsequent face-to-face consultation) cohorts. Hazard ratios (HR) were calculated using Cox regression model. Kaplan-Meier probability analysis (with 95% CIs) of subsequent face-to-face consultation was performed. Case examples highlighting potential harm were summarized.

Results

In total, 302 e-consults were reviewed. The most frequent referrals were for headache (n=125, 41.4%), dysesthesia (n=40, 13.2%), and abnormal imaging finding (n=27, 8.9%). The most common e-consult questions were for treatment (57.6%) and diagnostic evaluation (48.0%) recommendations. Moreover, 24.8% (n=75) of e-consults were followed by face-to-face consultations, with primary risk factors including female sex (HR, 1.9), referral for headache (HR, 1.7), and final diagnosis of migraine (HR, 2.0) or long-term migraine (HR, 5.0). Potential harm related to delayed diagnosis/treatment was identified in 6 (2.0%) patients with migraine and 4 (1.3%) without migraine presenting to emergency department.

Conclusion

Utilization of e-consults may safely improve access to neurologic expertise and prevent the need for some visits, which may have required a face-to-face visit. In patients with chronic migraine, e-consults should be considered short-term and followed by face-to-face consultation as soon as access allows. Neurologists performing e-consults should be able to triage patients to face-to-face consultation, particularly when diagnosis is uncertain or the neurologic examination may help guide appropriate testing.

目标描述我们的电子会诊(e-consults)实践,并评估后续面对面会诊的安全性和风险因素。患者和方法对 2018 年 5 月 5 日至 2019 年 6 月 31 日期间在社区神经内科完成的所有电子会诊进行回顾性队列研究。比较了成功组群和不成功组群(以是否存在后续面对面会诊为标准)的临床和人口统计学变量。使用 Cox 回归模型计算危险比(HR)。进行了后续面对面咨询的 Kaplan-Meier 概率分析(含 95% CIs)。对突出潜在危害的案例进行了总结。最常见的转诊病例为头痛(125例,41.4%)、疼痛(40例,13.2%)和影像异常(27例,8.9%)。最常见的电子会诊问题是治疗建议(57.6%)和诊断评估建议(48.0%)。此外,24.8%(n=75)的电子会诊后进行了面对面会诊,主要风险因素包括女性(HR,1.9)、头痛转诊(HR,1.7)、偏头痛最终诊断(HR,2.0)或长期偏头痛(HR,5.0)。6名(2.0%)偏头痛患者和4名(1.3%)无偏头痛患者在急诊科就诊时发现了与诊断/治疗延迟相关的潜在危害。对于慢性偏头痛患者,电子会诊应视为短期行为,一旦条件允许,应立即进行面对面会诊。进行电子会诊的神经科医生应能将患者分流至面对面会诊,尤其是在诊断不确定或神经检查有助于指导适当检查的情况下。
{"title":"Electronic Consultations in a Community Neurology Practice: A Retrospective Study Informing Best Practice","authors":"Nathan A. Seven MD ,&nbsp;Karen A. Truitt DO ,&nbsp;Ross A. Dierkhising MS ,&nbsp;Nathan P. Young DO","doi":"10.1016/j.mayocpiqo.2023.11.003","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.11.003","url":null,"abstract":"<div><h3>Objective</h3><p>To describe our practice of electronic consultations (e-consults) and assess safety and risk factors for subsequent face-to-face consultations.</p></div><div><h3>Patients and Methods</h3><p>A retrospective cohort study of all e-consults completed in a community neurology practice between May 5, 2018, and June 31, 2019, was completed. Clinical and demographic variables were compared between the successful and unsuccessful (defined by presence of subsequent face-to-face consultation) cohorts. Hazard ratios (HR) were calculated using Cox regression model. Kaplan-Meier probability analysis (with 95% CIs) of subsequent face-to-face consultation was performed. Case examples highlighting potential harm were summarized.</p></div><div><h3>Results</h3><p>In total, 302 e-consults were reviewed. The most frequent referrals were for headache (n=125, 41.4%), dysesthesia (n=40, 13.2%), and abnormal imaging finding (n=27, 8.9%). The most common e-consult questions were for treatment (57.6%) and diagnostic evaluation (48.0%) recommendations. Moreover, 24.8% (n=75) of e-consults were followed by face-to-face consultations, with primary risk factors including female sex (HR, 1.9), referral for headache (HR, 1.7), and final diagnosis of migraine (HR, 2.0) or long-term migraine (HR, 5.0). Potential harm related to delayed diagnosis/treatment was identified in 6 (2.0%) patients with migraine and 4 (1.3%) without migraine presenting to emergency department.</p></div><div><h3>Conclusion</h3><p>Utilization of e-consults may safely improve access to neurologic expertise and prevent the need for some visits, which may have required a face-to-face visit. In patients with chronic migraine, e-consults should be considered short-term and followed by face-to-face consultation as soon as access allows. Neurologists performing e-consults should be able to triage patients to face-to-face consultation, particularly when diagnosis is uncertain or the neurologic examination may help guide appropriate testing.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 17-27"},"PeriodicalIF":0.0,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000747/pdfft?md5=34d543c79ed67e1a33863ede1816bd8e&pid=1-s2.0-S2542454823000747-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139038572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consecutive Transcutaneous and Epidural Spinal Cord Neuromodulation to Modify Clinical Complete Paralysis—the Proof of Concept 连续经皮和硬膜外脊髓神经调控改变临床完全瘫痪--概念验证
Pub Date : 2023-12-14 DOI: 10.1016/j.mayocpiqo.2023.09.006
Elvira Mukhametova MD , Alena Militskova MS , Artur Biktimirov MD , Nikita Kharin MS , Elena Semenova MS , Oskar Sachenkov PhD , Tatiana Baltina PhD , Igor Lavrov MD, PhD

Objective

To evaluate the effect of transcutaneous (tSCS) and epidural electrical spinal cord stimulation (EES) in facilitating volitional movements, balance, and nonmotor functions, in this observational study, tSCS and EES were consecutively tested in 2 participants with motor complete spinal cord injury (SCI).

Participants and Methods

Two participants (a 48-year-old woman and a 28-year-old man), both classified as motor complete spinal injury, were enrolled in the study. Both participants went through a unified protocol, such as an initial electrophysiological assessment of neural connectivity, consecutive tSCS and EES combined with 8 wks of motor training with electromyography (EMG) and kinematic evaluation. The study was conducted from May 1, 2019, to December 31, 2021.

Results

In both participants, tSCS reported a minimal improvement in voluntary movements still essential to start tSCS-enabled rehabilitation. Compared with tSCS, following EES showed immediate improvement in voluntary movements, whereas tSCS was more effective in improving balance and posture. Continuous improvement in nonmotor functions was found during tSCS-enabled and then during EES-enabled motor training.

Conclusion

Results report a significant difference in the effect of tSCS and EES on the recovery of neurologic functions and support consecutive tSCS and EES applications as a potential therapy for SCI. The proposed approach may help in selecting patients with SCI responsive to neuromodulation. It would also help initiate neuromodulation and rehabilitation therapy early, particularly for motor complete SCI with minimal effect from conventional rehabilitation.

目的观察经皮脊髓电刺激(tSCS)和硬膜外脊髓电刺激(EES)在促进意志运动、平衡和非运动功能方面的作用,对2例运动性完全性脊髓损伤(SCI)患者连续进行tSCS和EES测试。参与者和方法两名参与者(一名48岁的女性和一名28岁的男性)均被归类为运动性完全性脊髓损伤。两名参与者都通过了统一的方案,如神经连通性的初始电生理评估,连续的tSCS和EES结合8周的运动训练与肌电图(EMG)和运动学评估。该研究于2019年5月1日至2021年12月31日进行。结果在两名参与者中,tSCS报告了自愿运动的微小改善,这仍然是开始tSCS支持的康复所必需的。与tSCS相比,EES在自主运动方面立即得到改善,而tSCS在改善平衡和姿势方面更有效。非运动功能的持续改善在激活tscs和激活ees的运动训练期间被发现。结论tSCS和EES对神经功能恢复的影响有显著差异,并支持连续应用tSCS和EES作为脊髓损伤的潜在治疗方法。该方法可能有助于选择对神经调节有反应的脊髓损伤患者。它也有助于早期启动神经调节和康复治疗,特别是对运动完全性脊髓损伤,传统康复治疗效果最小。
{"title":"Consecutive Transcutaneous and Epidural Spinal Cord Neuromodulation to Modify Clinical Complete Paralysis—the Proof of Concept","authors":"Elvira Mukhametova MD ,&nbsp;Alena Militskova MS ,&nbsp;Artur Biktimirov MD ,&nbsp;Nikita Kharin MS ,&nbsp;Elena Semenova MS ,&nbsp;Oskar Sachenkov PhD ,&nbsp;Tatiana Baltina PhD ,&nbsp;Igor Lavrov MD, PhD","doi":"10.1016/j.mayocpiqo.2023.09.006","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.09.006","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effect of transcutaneous (tSCS) and epidural electrical spinal cord stimulation (EES) in facilitating volitional movements, balance, and nonmotor functions, in this observational study, tSCS and EES were consecutively tested in 2 participants with motor complete spinal cord injury (SCI).</p></div><div><h3>Participants and Methods</h3><p>Two participants (a 48-year-old woman and a 28-year-old man), both classified as motor complete spinal injury, were enrolled in the study. Both participants went through a unified protocol, such as an initial electrophysiological assessment of neural connectivity, consecutive tSCS and EES combined with 8 wks of motor training with electromyography (EMG) and kinematic evaluation. The study was conducted from May 1, 2019, to December 31, 2021.</p></div><div><h3>Results</h3><p>In both participants, tSCS reported a minimal improvement in voluntary movements still essential to start tSCS-enabled rehabilitation. Compared with tSCS, following EES showed immediate improvement in voluntary movements, whereas tSCS was more effective in improving balance and posture. Continuous improvement in nonmotor functions was found during tSCS-enabled and then during EES-enabled motor training.</p></div><div><h3>Conclusion</h3><p>Results report a significant difference in the effect of tSCS and EES on the recovery of neurologic functions and support consecutive tSCS and EES applications as a potential therapy for SCI. The proposed approach may help in selecting patients with SCI responsive to neuromodulation. It would also help initiate neuromodulation and rehabilitation therapy early, particularly for motor complete SCI with minimal effect from conventional rehabilitation.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 1-16"},"PeriodicalIF":0.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000644/pdfft?md5=c15d5171a92a6d907c575eb820ff6c71&pid=1-s2.0-S2542454823000644-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138633570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Stream Infections in COVID-19 Patients From a Tertiary Care Center in Lebanon: Causative Pathogens and Rates of Multi-Drug Resistant Organisms 黎巴嫩某三级医疗中心COVID-19患者的血流感染:致病病原体和多重耐药菌率
Pub Date : 2023-11-24 DOI: 10.1016/j.mayocpiqo.2023.10.001
Sarah B. Nahhal MD , Johnny Zakhour MD , Abdel Hadi Shmoury MD , Tedy Sawma MD , Sara F. Haddad MD , Tamara Abdallah MSc , Nada Kara Zahreddine CIC , Joseph Tannous MHRM , Nisrine Haddad Pharm D , Nesrine Rizk MD , Souha S. Kanj MD

Objective

To report the microbiological profile of the pathogens implicated in blood stream infections (BSI) in hospitalized coronavirus disease 2019 (COVID-19) patients and to examine the risk factors associated with multidrug-resistant organisms (MDROs) causing BSI.

Patients and Methods

Between March 2020 and September 2021, 1647 patients were hospitalized with COVID-19 at the American University of Beirut. From 85 patients, 299 positive blood cultures were reported to the Infection Control and Prevention Program. The BSI was defined as 1 positive blood culture for bacterial or fungal pathogens. The following organisms were considered MDROs: methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp, carbapenem-resistant Enterobacterales spp., carbapenem-resistant Pseudomonas aeruginosa, MDR Acinetobacter baumannii only susceptible to colistin or tigecycline, and Candida auris.

Results

We identified 99 true positive BSI events. Gram-negative bacteria accounted for 38.4 %, followed by Gram-positive bacteria (37.4%), and fungi (24.2%). The most isolated species were Candida spp. (23%), 3 of which were C. auris, followed by Enterobacterales spp. (13%), Enterococcus spp. (12%), S. aureus (9%), P. aeruginosa (9%), and A. baumannii (3%). The MDROs represented 26% of the events. The overall mortality rate was 78%. The time to acquisition of BSI in patients with MDROs was significantly longer compared with that of non-MDROs (20.2 days vs 11.2 days). And there was a significantly shorter time from acquisition of BSI to mortality between MDROs and non-MDROs (1.5 vs 8.3 days).

Conclusion

Rigorous infection prevention and control measures and antimicrobial stewardship are important to prevent antimicrobial resistance progression, especially in low-resource settings.

目的报告2019冠状病毒病(COVID-19)住院患者血流感染(BSI)病原菌的微生物学特征,探讨多药耐药菌(mdro)引起BSI的相关危险因素。患者和方法在2020年3月至2021年9月期间,贝鲁特美国大学有1647名患者因COVID-19住院。从85名患者中,299例阳性血培养报告给感染控制和预防计划。BSI定义为1个细菌或真菌病原体血培养阳性。以下生物被认为是耐药细菌:耐甲氧西林金黄色葡萄球菌、耐万古霉素肠球菌、耐碳青霉烯肠杆菌、耐碳青霉烯铜绿假单胞菌、耐多药鲍曼不动杆菌仅对粘菌素或替加环素敏感,以及金黄色念珠菌。结果共鉴定出99例BSI真阳性事件。革兰氏阴性菌占38.4%,革兰氏阳性菌占37.4%,真菌占24.2%。检出最多的菌种是念珠菌(23%),其中金黄色葡萄球菌(C. auris) 3种,其次是肠杆菌(13%)、肠球菌(12%)、金黄色葡萄球菌(9%)、铜绿假单胞菌(9%)和鲍曼不动杆菌(3%)。mdro代表了26%的事件。总死亡率为78%。与非mdro患者相比,mdro患者获得BSI的时间明显更长(20.2天vs 11.2天)。mdro和非mdro之间从获得BSI到死亡的时间明显更短(1.5天对8.3天)。结论严格的感染防控措施和抗菌药物管理是防止耐药性发展的重要措施,特别是在资源匮乏地区。
{"title":"Blood Stream Infections in COVID-19 Patients From a Tertiary Care Center in Lebanon: Causative Pathogens and Rates of Multi-Drug Resistant Organisms","authors":"Sarah B. Nahhal MD ,&nbsp;Johnny Zakhour MD ,&nbsp;Abdel Hadi Shmoury MD ,&nbsp;Tedy Sawma MD ,&nbsp;Sara F. Haddad MD ,&nbsp;Tamara Abdallah MSc ,&nbsp;Nada Kara Zahreddine CIC ,&nbsp;Joseph Tannous MHRM ,&nbsp;Nisrine Haddad Pharm D ,&nbsp;Nesrine Rizk MD ,&nbsp;Souha S. Kanj MD","doi":"10.1016/j.mayocpiqo.2023.10.001","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.10.001","url":null,"abstract":"<div><h3>Objective</h3><p>To report the microbiological profile of the pathogens implicated in blood stream infections (BSI) in hospitalized coronavirus disease 2019 (COVID-19) patients and to examine the risk factors associated with multidrug-resistant organisms (MDROs) causing BSI.</p></div><div><h3>Patients and Methods</h3><p>Between March 2020 and September 2021, 1647 patients were hospitalized with COVID-19 at the American University of Beirut. From 85 patients, 299 positive blood cultures were reported to the Infection Control and Prevention Program. The BSI was defined as 1 positive blood culture for bacterial or fungal pathogens. The following organisms were considered MDROs: methicillin-resistant <em>Staphylococcus aureus</em>, vancomycin-resistant <em>Enterococcus</em> spp, carbapenem-resistant <em>Enterobacterales</em> spp., carbapenem-resistant <em>Pseudomonas aeruginosa</em>, MDR <em>Acinetobacter baumannii</em> only susceptible to colistin or tigecycline, and <em>Candida auris.</em></p></div><div><h3>Results</h3><p>We identified 99 true positive BSI events. Gram-negative bacteria accounted for 38.4 %, followed by Gram-positive bacteria (37.4%), and fungi (24.2%). The most isolated species were <em>Candida</em> spp. (23%), 3 of which were <em>C. auris</em>, followed by <em>Enterobacterales</em> spp. (13%), <em>Enterococcus</em> spp. (12%), <em>S. aureus</em> (9%), <em>P. aeruginosa</em> (9%), and <em>A. baumannii</em> (3%). The MDROs represented 26% of the events. The overall mortality rate was 78%. The time to acquisition of BSI in patients with MDROs was significantly longer compared with that of non-MDROs (20.2 days vs 11.2 days). And there was a significantly shorter time from acquisition of BSI to mortality between MDROs and non-MDROs (1.5 vs 8.3 days).</p></div><div><h3>Conclusion</h3><p>Rigorous infection prevention and control measures and antimicrobial stewardship are important to prevent antimicrobial resistance progression, especially in low-resource settings.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"7 6","pages":"Pages 556-568"},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000681/pdfft?md5=b0a82eabdc062d57635e0b37f75841c8&pid=1-s2.0-S2542454823000681-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138413007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a Wellness Leadership Intervention on the Empathy, Burnout, and Resting Heart Rate of Medical Faculty 健康领导干预对医务人员共情、倦怠和静息心率的影响
Pub Date : 2023-11-23 DOI: 10.1016/j.mayocpiqo.2023.09.005
Debra A. Gilin PhD , Gregory G. Anderson MSc , Seyedehsan Etezad MSc , Dayna Lee-Baggley PhD , Angela M. Cooper PhD, RPsych , Roberta J. Preston EdD

Objective

To evaluate the efficacy of a wellness leadership intervention for improving the empathy, burnout, and physiological stress of medical faculty leaders.

Participants and Methods

Participants were 49 medical faculty leaders (80% physicians, 20% basic scientists; 67% female). The 6-week course was evaluated with a 15-week longitudinal waitlist-control quasi-experiment from September 1, 2021, through December 20, 2021 (during the COVID-19 pandemic). We analyzed 3 pretest-posttest-posttest and 6 weekly survey measurements of affective empathy and burnout, and mean=85 (SD=31) aggregated daily resting heart rates per participant, using 2-level hierarchical linear modeling.

Results

The course found a preventive effect for leaders’ burnout escalation. As the control group awaited the course, their empathy decreased (coefficientTime=−1.27; P=.02) and their resting heart rates increased an average of 1.4 beats/min (coefficientTime=0.18; P<.001), reflecting the toll of the pandemic. Intervention group leaders reported no empathy decrements (coefficientTime=.33; P=.59) or escalated resting heart rate (coefficientTime=−0.05; P=.27) during the same period. Dose-response analysis revealed that both groups reduced their self-rated burnout over the 6 weeks of the course (coefficientTime=−0.28; P=.007), and those who attended more of the course showed less heart rate increase (coefficientTime∗Dosage=−0.05; P<.001). In addition, 12.73% of the within-person fluctuation in empathy was associated with burnout and resting heart rate.

Conclusion

A wellness leadership intervention helped prevent burnout escalation and empathy decrement in medical faculty leaders during the COVID-19 pandemic, showing potential to improve the supportiveness and psychological safety of the medical training environment.

目的评价健康领导干预对改善医学院领导共情、倦怠和生理应激的效果。参与者和方法49名医学院领导(80%为内科医生,20%为基础科学家;67%的女性)。从2021年9月1日至2021年12月20日(COVID-19大流行期间),通过为期15周的纵向候补名单对照准实验对为期6周的课程进行评估。我们分析了3次前测-后测-后测和6次每周情感共情和倦怠的调查测量结果,并使用两级层次线性模型,得出每位参与者的平均每日静息心率=85 (SD=31)。结果该课程对领导倦怠升级具有预防作用。当对照组等待课程时,他们的同理心减少(系数时间= - 1.27;P= 0.02),静息心率平均增加1.4次/分(coefficientTime=0.18;P<.001),反映了大流行造成的损失。干预组组长未报告共情能力下降(coefficientTime=.33;P= 0.59)或静息心率升高(coefficientTime=−0.05;P=.27)。剂量反应分析显示,两组在6周的课程中都减少了他们的自评倦怠(系数时间= - 0.28;P=.007),而那些参加更多课程的人心率增加较少(系数时间*剂量= - 0.05;术;措施)。此外,12.73%的共情情绪波动与倦怠和静息心率相关。结论健康领导干预有助于预防新冠肺炎大流行期间医学教师领导的倦怠升级和共情下降,显示出改善医学培训环境的支持性和心理安全性的潜力。
{"title":"Impact of a Wellness Leadership Intervention on the Empathy, Burnout, and Resting Heart Rate of Medical Faculty","authors":"Debra A. Gilin PhD ,&nbsp;Gregory G. Anderson MSc ,&nbsp;Seyedehsan Etezad MSc ,&nbsp;Dayna Lee-Baggley PhD ,&nbsp;Angela M. Cooper PhD, RPsych ,&nbsp;Roberta J. Preston EdD","doi":"10.1016/j.mayocpiqo.2023.09.005","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.09.005","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the efficacy of a wellness leadership intervention for improving the empathy, burnout, and physiological stress of medical faculty leaders.</p></div><div><h3>Participants and Methods</h3><p>Participants were 49 medical faculty leaders (80% physicians, 20% basic scientists; 67% female). The 6-week course was evaluated with a 15-week longitudinal waitlist-control quasi-experiment from September 1, 2021, through December 20, 2021 (during the COVID-19 pandemic). We analyzed 3 pretest-posttest-posttest and 6 weekly survey measurements of affective empathy and burnout, and mean=85 (SD=31) aggregated daily resting heart rates per participant, using 2-level hierarchical linear modeling.</p></div><div><h3>Results</h3><p>The course found a preventive effect for leaders’ burnout escalation. As the control group awaited the course, their empathy decreased (coefficient<sub>Time</sub>=−1.27; <em>P</em>=.02) and their resting heart rates increased an average of 1.4 beats/min (coefficient<sub>Time</sub>=0.18; <em>P</em>&lt;.001), reflecting the toll of the pandemic. Intervention group leaders reported no empathy decrements (coefficient<sub>Time</sub>=.33; <em>P</em>=.59) or escalated resting heart rate (coefficient<sub>Time</sub>=−0.05; <em>P</em>=.27) during the same period. Dose-response analysis revealed that both groups reduced their self-rated burnout over the 6 weeks of the course (coefficient<sub>Time</sub>=−0.28; <em>P</em>=.007), and those who attended more of the course showed less heart rate increase (coefficient<sub>Time∗Dosage</sub>=−0.05; <em>P</em>&lt;.001). In addition, 12.73% of the within-person fluctuation in empathy was associated with burnout and resting heart rate.</p></div><div><h3>Conclusion</h3><p>A wellness leadership intervention helped prevent burnout escalation and empathy decrement in medical faculty leaders during the COVID-19 pandemic, showing potential to improve the supportiveness and psychological safety of the medical training environment.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"7 6","pages":"Pages 545-555"},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000632/pdfft?md5=06b08332fb7a367a7844d8925992f219&pid=1-s2.0-S2542454823000632-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138413122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewers for Mayo Clinic Proceedings: Innovations, Quality & Outcomes (2023) 《梅奥诊所学报:创新、质量和结果》(2023)审稿人
Pub Date : 2023-11-21 DOI: 10.1016/j.mayocpiqo.2023.11.001
{"title":"Reviewers for Mayo Clinic Proceedings: Innovations, Quality & Outcomes (2023)","authors":"","doi":"10.1016/j.mayocpiqo.2023.11.001","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.11.001","url":null,"abstract":"","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"7 6","pages":"Page 544"},"PeriodicalIF":0.0,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000693/pdfft?md5=70fcc57497e954d787a2150e0af9d0d0&pid=1-s2.0-S2542454823000693-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138430365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Mayo Clinic proceedings. Innovations, quality & outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1